Literature DB >> 21118622

Growth in children and adolescents with sickle cell disease in Yemen.

A-W M Al-Saqladi1, H A Bin-Gadeen, B J Brabin.   

Abstract

BACKGROUND: Physical growth is known to be impaired in children with sickle cell disease (SCD) and the prevalence and severity vary with geographical location. The factors which contribute to this sub-optimal growth are poorly understood.
OBJECTIVES: To describe the growth status of children and adolescents with SCD in Yemen using the new WHO reference values and to assess correlation of growth indicators with disease severity and with haematological and biochemical parameters.
METHODS: A cross-sectional study of children <16 years with SCD was conducted at Al-Wahda General Teaching Hospital, Aden. Anthropometric measurements of weight, length/height, mid-upper-arm circumference (MUAC) and body mass index (BMI) were collected. Disease severity was assessed using a severity index (SI) score.
RESULTS: A total of 102 children (56 male) were included and their mean age was 7.2 years (range 6 months to 15 years). Low weight, height and BMI-for-age Z-scores (<-2 SD) were observed in 45%, 54% and 35% of children, respectively. Regression analyses indicated an association of low height-for-age with male gender (p=0.02), low weight-for-age and weight-for-height with increased age (both p<0.001), low weight-for-age with raised alkaline phosphatase (p=0.04), and low BMI with reduced plasma albumin (p=0.04). There was no correlation between growth deficits and SI or anaemia severity.
CONCLUSION: Growth is severely impaired in children and adolescents with SCD in Yemen. Growth monitoring and nutritional support should be included in their comprehensive care package.

Entities:  

Mesh:

Year:  2010        PMID: 21118622     DOI: 10.1179/146532810X12858955921113

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  8 in total

1.  Hydroxyurea and growth in young children with sickle cell disease.

Authors:  Sohail Rana; Patricia E Houston; Winfred C Wang; Rathi V Iyer; Jonathan Goldsmith; James F Casella; Caroline K Reed; Zora R Rogers; Myron A Waclawiw; Bruce Thompson
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

2.  Frequency and risk factors of endocrine complications in Turkish children and adolescents with sickle cell anemia.

Authors:  Samim Ozen; Selma Unal; Neslihan Erçetin; Bahar Taşdelen
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

3.  Head circumference of children with sickle cell disease in Lagos, Nigeria.

Authors:  Idowu Odunayo Senbanjo; Kazeem Adeola Oshikoya; Mohammed Salisu; Ijeoma Nnenna Diaku-Akinwumi
Journal:  Pan Afr Med J       Date:  2016-09-13

4.  Factors Associated with Growth Retardation in Children Suffering from Sickle Cell Anemia: First Report from Central Africa.

Authors:  Aimé Lukusa Kazadi; René Makuala Ngiyulu; Jean Lambert Gini-Ehungu; Jean Marie Mbuyi-Muamba; Michel Ntetani Aloni
Journal:  Anemia       Date:  2017-01-30

5.  SOCIOECONOMIC AND NUTRITIONAL CHARACTERISTICS OF CHILDREN AND ADOLESCENTS WITH SICKLE CELL ANEMIA: A SYSTEMATIC REVIEW.

Authors:  Amanda Cristina da Silva de Jesus; Tulio Konstantyner; Ianna Karolina Véras Lôbo; Josefina Aparecida Pellegrini Braga
Journal:  Rev Paul Pediatr       Date:  2018 Oct-Dec

6.  A cross sectional study of growth of children with sickle cell disease, aged 2 to 5 years in Yaoundé, Cameroon.

Authors:  Suzanne Sap Ngo Um; Judith Seungue; Anastasie Yanda Alima; Ritha Mbono; Hubert Mbassi; David Chelo; Paul Olivier Koki
Journal:  Pan Afr Med J       Date:  2019-10-13

7.  Association of sickle cell disease with anthropometric indices among under-five children: evidence from 2018 Nigeria Demographic and Health Survey.

Authors:  Mohammad Redwanul Islam; Md Moinuddin; Ayeda Ahmed; Syed Moshfiqur Rahman
Journal:  BMC Med       Date:  2021-01-15       Impact factor: 8.775

8.  Wasting and stunting are still prevalent in children with sickle cell anaemia in Lagos, Nigeria.

Authors:  Christopher I Esezobor; Patricia Akintan; Adebola Akinsulie; Edamisan Temiye; Titilope Adeyemo
Journal:  Ital J Pediatr       Date:  2016-05-04       Impact factor: 2.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.